Jazz Pharmaceuticals, Inc. drugs

9 results
  • defitelio - defibrotide sodium injection, solution

    (Defibrotide Sodium)
    Jazz Pharmaceuticals, Inc.
    Defitelio treats hepatic veno-occlusive disease (VOD), also called sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction in adults and children following hematopoietic stem-cell transplantation (HSCT).
  • epidiolex - cannabidiol solution

    (Cannabidiol)
    Jazz Pharmaceuticals, Inc.
    Epidiolex treats seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 1 year of age and older.
  • modeyso - dordaviprone capsule

    (Dordaviprone)
    Jazz Pharmaceuticals, Inc.
    Modeyso treats diffuse midline glioma with H3 K27M mutation in adults and children 1 year and older with progressive disease after prior therapy. Approved under accelerated approval based on response rate.
  • rylaze - asparaginase erwinia chrysanthemi

    (Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn)
    Jazz Pharmaceuticals, Inc.
    Rylaze is used as part of combination chemotherapy to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase.
  • vyxeos-

    ((Daunorubicin And Cytarabine) Liposome)
    Jazz Pharmaceuticals, Inc.
    Vyxeos treats newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients aged 1 year and older.
  • xywav - calcium, magnesium, potassium, and sodium oxybates solution

    (Calcium, Magnesium, Potassium, And Sodium Oxybates)
    Jazz Pharmaceuticals, Inc.
    Xywav treats cataplexy and excessive daytime sleepiness in patients 7 years and older with narcolepsy, and idiopathic hypersomnia in adults.
  • zepzelca - lurbinectedin injection, powder, lyophilized, for solution

    (Lurbinectedin)
    Jazz Pharmaceuticals, Inc.
    Zepzelca treats adults with small cell lung cancer: as maintenance therapy (with atezolizumab) for extensive-stage SCLC after first-line induction, and for metastatic SCLC that progressed on or after platinum-based chemotherapy (accelerated approval).